External Beam Radiation Therapy for Metastatic Tumor to the Iris: A Case Report and Brief Literature Review

Special Issue - Tumor Diagnostic and Treatment

J Ophthalmol & Vis Sci. 2021; 6(2): 1052.

External Beam Radiation Therapy for Metastatic Tumor to the Iris: A Case Report and Brief Literature Review

Clyde JW¹, Sakthivel G¹, Mulford D² and Singh DP¹*

1Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA

2Department of Medical Oncology; University of Rochester Medical Center, Rochester, NY, USA

*Corresponding author: Singh DP, Department of Radiation Oncology, University of Rochester Medical Center, 601 Elmwood Ave, Box 647, Rochester, NY 14642, USA

Received: June 23, 2021; Accepted: July 10, 2021; Published: July 17, 2021

Abstract

Tumor metastases involving the iris are rare and represent about 3% of metastases to the uveal tract. The typical presentation is a patient with a known history of carcinoma who develops blurry vision, ocular pain, and/or eye redness, which may be erroneously diagnosed as uveitis. In this case, we report the workup, diagnosis, and treatment of a 76 year old man with a history of node negative multi-focal adenocarcinoma of the lung who was found to have a left iris metastasis. He presented with blurry vision and left eye pain. Exam revealed a 7 x 7 mm amelanotic ciliary body mass, which was ultimately biopsied and found to be consistent with his lung primary. He was treated with external beam radiation therapy, 3000cGy in 10 fractions, to the left globe. His three and nine-month follow up MRIs showed good treatment response and he is clinically without disease progression. EBRT is a safe and effective modality for the treatment of iris metastases.

Keywords: Iris metastasis; Uveal tract metastasis; Ocular metastasis; Radiation therapy

Introduction

Ocular metastases are rare and most often occur in the posterior uvea. Metastases to the iris represent only about 3% of all uveal metastases [1]. The primary sites that most commonly metastasize to the iris are breast, lung, carcinoid, and melanoma. Patients typically present with blurred vision, ocular pain, photophobia, redness, and in some cases a visible iris mass. Due to the infrequency with which carcinoma metastasizes to the iris, these lesions are often misdiagnosed as uveitis [2-5].

In this case report, we describe a patient who was found to have a metastatic tumor of the iris and was treated with external beam radiation therapy (EBRT) with symptomatic improvement and local control. Our Institutional Research Subject Review Board does not require informed consent from patients for a case report.

Case Presentation

A 76-year-old man underwent wedge resections of the right upper lobe, middle lobe, and lower lobe for presumed node negative multifocal adenocarcinoma. He subsequently underwent stereotactic body radiotherapy (SBRT) for a left lung nodule in February 2020.

Near the end of March 2020, the patient developed blurry vision and left eye pain. He was seen by ophthalmology and was treated with a prednisolone ophthalmic solution for acute anterior intraocular inflammation of the left eye. His symptoms persisted, and upon further examination was found to have an amelanotic ciliary body mass with anterior uveitis concerning for a granuloma vs neoplasm. Iris angiography of the left eye revealed leakage and internal vascularization of the mass. The patient was referred to an ocular oncologist and had an FNA biopsy, which was consistent with adenocarcinoma. Additional workup with an MRI revealed a 7 x 7 mm inferotemporal nodular enhancing lesion arising from the ciliary body (Figure 1). Restaging scans also identified two pelvic osseous metastases.